The factors affecting bone density in cirrhosis

Hepatitis Monthly

Volumn 15, Issue 4, 2015, Pages

  Hajiabbasi, Asghar ^a   Shafaghi, Afshin ^b   Fayazi, Haniyeh Sadat ^a   Masooleh, Irandokht Shenavar ^a   Emami, Mohammad Hassan Hedayati ^a   Parsa, Pooneh Ghavidel ^a   Maafi, Alireza Amir ^c  

^a GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bone density; Liver cirrhosis; Osteoporosis

Indexed keywords

VITAMIN D;

ADULT; ARTICLE; BONE DENSITY; CROSS-SECTIONAL STUDY; DENSITOMETRY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GLOMERULUS FILTRATION RATE; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MILD HEPATIC IMPAIRMENT; MODERATE HEPATIC IMPAIRMENT; MODERATE RENAL IMPAIRMENT; MULTIVARIATE ANALYSIS; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; SEVERE HEPATIC IMPAIRMENT; SMOKING; UNIVARIATE ANALYSIS; VITAMIN BLOOD LEVEL;

EID: 84970031910     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.15(4)2015.26871     Document Type: Article

References (28)

1. Felecia C, David D. Rheumatology. Mosbey: Elsevier; 2011. Pathogenesis of osteoporosis.Pathogenesis of osteoporosis.
2. Lane NE. Metabolic Bone Disease. In: Firestein GS, Budd RC, Gabriel EG, Mcinnes IB, O'dell JR editors. Kelley's Textbook of Rheumatology.; 2013. pp. 1660–79.
3. Bringhust FR, Demay MB, Krane SM, Konenberg HM. Bone and Mineral Metabolism in Health and Disease. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J editors. Harrison's Principles of Internal Medicine. 18th ed; 2012. pp. 3082–95.
4. Luxon BA. Bone disorders in chronic liver diseases. Curr Gastroenterol Rep. 2011;13(1):40–8.
5. Guanabens N, Pares A. Liver and bone. Arch Biochem Biophys. 2010;503(1):84–94.
6. Soylu AR, Tuglu C, Arikan E, Yetisyigit T, Kunduracılar H, Koker IH, et al. The Role of Serum Cytokines in the Pathogenesis of Hepatic Osteodystrophy in Male Cirrhotic Patients. Gastroenterol Res Pract. 2012;2012.
7. Goral V, Simsek M, Mete N. Hepatic osteodystrophy and liver cirrhosis. World J Gastroenterol. 2010;16(13):1639–43.
8. Collier JD, Ninkovic M, Compston JE. Guidelines on the management of osteoporosis associated with chronic liver disease. Gut. 2002;50 Suppl 1:i1–9.
9. Lewiecki EM, Rosen CJ. Overview of dual-energy x-ray absorptiometry.: UpToDate Marketing Professional; 2013. Available from: http://www.uptodate.com/contents/overview-of-dual-energy-x-ray-absorptiometry?source=search_result&search=DXA&selectedTitle=1~116.
10. Ghany MG, Hoofnagle JH. Approach to the patient with liver disease. In: Longo DL, Fauci AS, Hauser SL, Jameson JL, Loscalzo J editors. Harrison's Principles of Internal Medicine. 18th ed; 2012. pp. 2520–6.
11. Moradzadeh K, Larijani B, Keshtkar AA, Hossein-Nezhad A, Rajabian R, Nabipour I, et al. Normative values of vitamin D among Iranian population: a population based study. In J Osteoporos Metab Disord. 2008;1(1):8–15.
12. Fahimi S, Pharoah P. Reducing salt intake in Iran: priorities and challenges. Arch Iran Med. 2012;15(2):110–2.
13. World Health Organization.. Country profile Iran. 2011. Available from: http://www.who.int/nmh/countries/2011/irn_en.pdf.
14. World Health Organization.. WHO Report on the Global Tobacco Epidemic, 2013. Country profile. Iran (Islamic Republic of). 2013. Available from: http://www.who.int/tobacco/surveillance/policy/country_profile/irn.pdf?ua=1.
15. Irani AD, Poorolajal J, Khalilian A, Esmailnasab N, Cheraghi Z. Prevalence of osteoporosis in Iran: A meta-analysis. J Res Med Sci. 2013;18(9):759–66.
16. Sokhi RP, Anantharaju A, Kondaveeti R, Creech SD, Islam KK, Van Thiel DH. Bone mineral density among cirrhotic patients awaiting liver transplantation. Liver Transpl. 2004;10(5):648–53.
17. Ninkovic M, Love SA, Tom B, Alexander GJ, Compston JE. High prevalence of osteoporosis in patients with chronic liver disease prior to liver transplantation. Calcif Tissue Int. 2001;69(6):321–6.
18. Loria I, Albanese C, Giusto M, Galtieri PA, Giannelli V, Lucidi C, et al. Bone disorders in patients with chronic liver disease awaiting liver transplantation. Transplant Proc. 2010;42(4):1191–3.
19. Alcalde Vargas A, Pascasio Acevedo JM, Gutierrez Domingo I, Garcia Jimenez R, Sousa Martin JM, Ferrer Rios MT, et al. Prevalence and characteristics of bone disease in cirrhotic patients under evaluation for liver transplantation. Transplant Proc. 2012;44(6):1496–8.
20. lindsay R, Cosman F. Osteoporosis. In: Longo DL, Fauci AS, Kasper LD, Hauser SL, Jameson JL editors. Harrison's Principles of Internal Medicine. 18th ed; 2012. pp. 3120–35.
21. Giouleme OI, Vyzantiadis TA, Nikolaidis NL, Vasiliadis TG, Papageorgiou AA, Eugenidis NP, et al. Pathogenesis of osteoporosis in liver cirrhosis. Hepatogastroenterology. 2006;53(72):938–43.
22. Rouillard S, Lane NE. Hepatic osteodystrophy. Hepatology. 2001;33(1):301–7.
23. Janes CH, Dickson ER, Okazaki R, Bonde S, McDonagh AF, Riggs BL. Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest. 1995;95(6):2581–6.
24. Francoz C, Glotz D, Moreau R, Durand F. The evaluation of renal function and disease in patients with cirrhosis. J Hepatol. 2010;52(4):605–13.
25. Teneva BH. Pathogenesis and assessment of renal function in patients with liver cirrhosis. Folia Med (Plovdiv). 2012;54(4):5–13.
26. Sherman DS, Fish DN, Teitelbaum I. Assessing renal function in cirrhotic patients: problems and pitfalls. Am J Kidney Dis. 2003;41(2):269–78.
27. Papadakis MA, Arieff AI. Unpredictability of clinical evaluation of renal function in cirrhosis. Prospective study. Am J Med. 1987;82(5):945–52.
28. Gines P, Guevara M, Arroyo V, Rodes J. Hepatorenal syndrome. Lancet. 2003;362(9398):1819–27.